141 related articles for article (PubMed ID: 34286723)
1. Aminocellulose - grafted polycaprolactone-coated core-shell nanoparticles alleviate the severity of ulcerative colitis: a novel adjuvant therapeutic approach.
Ahmad A; Ansari MM; Kumar A; Bishnoi M; Raza SS; Khan R
Biomater Sci; 2021 Sep; 9(17):5868-5883. PubMed ID: 34286723
[TBL] [Abstract][Full Text] [Related]
2. Enteric-coated gelatin nanoparticles mediated oral delivery of 5-aminosalicylic acid alleviates severity of DSS-induced ulcerative colitis.
Ahmad A; Ansari MM; Mishra RK; Kumar A; Vyawahare A; Verma RK; Raza SS; Khan R
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 119():111582. PubMed ID: 33321628
[TBL] [Abstract][Full Text] [Related]
3. Aminocellulose-grafted-polycaprolactone coated gelatin nanoparticles alleviate inflammation in rheumatoid arthritis: A combinational therapeutic approach.
Ansari MM; Ahmad A; Kumar A; Alam P; Khan TH; Jayamurugan G; Raza SS; Khan R
Carbohydr Polym; 2021 Apr; 258():117600. PubMed ID: 33593531
[TBL] [Abstract][Full Text] [Related]
4. Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis.
Sun L; Nie X; Lu W; Zhang Q; Fang W; Gao S; Chen S; Hu R
AAPS PharmSciTech; 2022 Jun; 23(6):179. PubMed ID: 35761150
[TBL] [Abstract][Full Text] [Related]
5. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L
Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486
[TBL] [Abstract][Full Text] [Related]
6. Colitis-targeted hybrid nanoparticles-in-microparticles system for the treatment of ulcerative colitis.
Naeem M; Lee J; Oshi MA; Cao J; Hlaing SP; Im E; Jung Y; Yoo JW
Acta Biomater; 2020 Oct; 116():368-382. PubMed ID: 32937207
[TBL] [Abstract][Full Text] [Related]
7. Caffeic Acid-Conjugated Budesonide-Loaded Nanomicelle Attenuates Inflammation in Experimental Colitis.
Mishra RK; Ahmad A; Kanika ; Kumar A; Vyawahare A; Sakla R; Nadeem A; Siddiqui N; Raza SS; Khan R
Mol Pharm; 2023 Jan; 20(1):172-182. PubMed ID: 36472567
[TBL] [Abstract][Full Text] [Related]
8. Thiol-Functionalized Cellulose-Grafted Copper Oxide Nanoparticles for the Therapy of Experimental Colitis in Swiss Albino Mice.
Mishra RK; Selim A; Gowri V; Ahmad A; Nadeem A; Siddiqui N; Raza SS; Jayamurugan G; Khan R
ACS Biomater Sci Eng; 2022 May; 8(5):2088-2095. PubMed ID: 35452219
[TBL] [Abstract][Full Text] [Related]
9. Enema based therapy using liposomal formulation of low molecular weight heparin for treatment of active ulcerative colitis: New adjunct therapeutic opportunity.
Ahmad A; Vaghasiya K; Kumar A; Alam P; Raza SS; Verma RK; Khan R
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111851. PubMed ID: 33579485
[TBL] [Abstract][Full Text] [Related]
10. Achillea wilhelmsii-Incorporated Chitosan@Eudragit Nanoparticles Intended for Enhanced Ulcerative Colitis Treatment.
Maleki H; Doostan M; Farzaei MH; Seifi P; Miraghaee S; Doostan M
AAPS PharmSciTech; 2023 Apr; 24(5):112. PubMed ID: 37118443
[TBL] [Abstract][Full Text] [Related]
11. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D
Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161
[TBL] [Abstract][Full Text] [Related]
12. Colon-Targeting
Xu Y; Zhu BW; Sun R; Li X; Wu D; Hu JN
ACS Appl Mater Interfaces; 2023 Jun; 15(22):26298-26315. PubMed ID: 37233992
[TBL] [Abstract][Full Text] [Related]
13. Preparation of Oral Core-Shell Zein Nanoparticles to Improve the Bioavailability of Glycyrrhizic Acid for the Treatment of Ulcerative Colitis.
Wu A; Chen C; Lu J; Sun J; Xiao M; Yue X; Zhou P; Zhao S; Zhong G; Huang C; Qu Y; Zhang C
Biomacromolecules; 2022 Jan; 23(1):210-225. PubMed ID: 34905341
[TBL] [Abstract][Full Text] [Related]
14. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D
Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741
[TBL] [Abstract][Full Text] [Related]
15. Curcumin Nanocrystal/pH-Responsive Polyelectrolyte Multilayer Core-Shell Nanoparticles for Inflammation-Targeted Alleviation of Ulcerative Colitis.
Oshi MA; Lee J; Naeem M; Hasan N; Kim J; Kim HJ; Lee EH; Jung Y; Yoo JW
Biomacromolecules; 2020 Sep; 21(9):3571-3581. PubMed ID: 32701266
[TBL] [Abstract][Full Text] [Related]
16. Oral Drug Delivery Systems for Ulcerative Colitis Therapy: A Comparative Study with Microparticles and Nanoparticles.
Ma P; Si X; Chen Q; Ma L; Hou M; Xu Z; Kang Y; Wang J; Xiao B
Curr Cancer Drug Targets; 2019; 19(4):304-311. PubMed ID: 30332962
[TBL] [Abstract][Full Text] [Related]
17. Surface-anchored microbial enzyme-responsive solid lipid nanoparticles enabling colonic budesonide release for ulcerative colitis treatment.
Zhang Y; Wang L; Wang ZD; Zhou Q; Zhou X; Zhou T; Guan YX; Liu X
J Nanobiotechnology; 2023 May; 21(1):145. PubMed ID: 37127609
[TBL] [Abstract][Full Text] [Related]
18. Development and
Singh A; Mandal UK; Narang RK
Assay Drug Dev Technol; 2022 Jan; 20(1):22-34. PubMed ID: 34780287
[TBL] [Abstract][Full Text] [Related]
19. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW
Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440
[TBL] [Abstract][Full Text] [Related]
20. Oral Delivery of Pterostilbene by L-Arginine-Mediated "Nano-Bomb" Carrier for the Treatment of Ulcerative Colitis.
Wei W; Zhang Y; Li R; Cao Y; Yan X; Ma Y; Zhang Y; Yang M; Zhang M
Int J Nanomedicine; 2022; 17():603-616. PubMed ID: 35177902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
